Translate page

Participating Centers of the Clinical Preceptorship Program

Preceptorships take place at twelve designated international specialist CML centres and last for 3-4 weeks. Host sites include English, French, Italian, Russian and Spanish speaking centres.

Find detailed descriptions of the participating centers here.

 

1) The Centre for Cancer Biology and Royal Adelaide Hospital, Adelaide, Australia11 Adelaide

The Centre for Cancer Biology (CCB) provides facilities for medical researchers in close collaboration with the University of Adelaide.  

The CCB is dedicated to excellence in basic and clinical research. Its primary goals are to make fundamental biological and biomedical discoveries, to provide an environment of world-class facilities necessary for conducting research at an international level and to establish the important linkage between basic scientists and clinicians thus facilitating the full development and application of the therapeutic potential of basic science discoveries.

Preceptorships in Adelaide will last 3 weeks. 

Preceptorship Program lead: Professor Timothy Hughestim hughes

 

2) S.Orsola-Malpighi University Hospital, Bologna, Italy12 Bologna 

With more than 400 years of history, The Bologna University Hospital Authority St. Orsola-Malpighi Polyclinic was the first hospital in Bologna and today is home to the School of Medicine and Surgery. The Polyclinic is an internationally acclaimed institution for the study and treatment of pathologies and each year organizes medical conferences and conventions attended by professionals of international fame.

Preceptorships in Bologna will last for 4 weeks. 

Preceptorship Program lead - Gianantonio Rosti MD13 Gianantonio Rosti

 

3) Centre Hospitalier Universitaire (CHU) de Bordeaux, Bordeaux, France17 Bordeaux

The third largest university hospital in France, the Bordeaux University Hospital comprises three hospital facilities located within the urban community. Closely related to the University Segalen Bordeaux 2, they participate consistently in medical training, as well as basic research.  Through its research activities Bordeaux Seglan University contributes to the major scientific and medical breakthroughs of the 21st century with over 100 research programs being implemented in collaboration with national and international research institutions. CML patients are treated at the Bergonie Institute, a center of excellence in the fight against cancer. The Institute has a sphere of medical expertise and advanced medical technology at the forefront of innovation to meet the needs of modern oncology and haematology. The aim of the Institute Bergonie is to improve and provide comprehensive and continuing patient care.

Preceptorships at CHU de Bordeaux will last for 3 to 4 weeks.

Preceptorship Program lead - Professor Francois-Xavier MahonDr Mahon

  

4) City of Hope, California, USACity of Hope 2

City of Hope is an independent research center, established in 1913, that is an NCI designated Comprehensive Cancer Center and a member of the NCCN (National Comprehensive Cancer Network). The Department of Hematology/HCT has one of the largest and most successful transplant programs in the United States. In addition, there is a strong Phase 1/New Drug Development program that oversees clinical trials for new therapeutic agents for leukemia, lymphoma, and myeloma. Drs. Ravi Bhatia and David Snyder are Co-Chairs of the CML Committee for City of Hope. Dr. Bhatia has a full time laboratory program studying leukemic stem cells. The Molecular Hematopathology Laboratory, under the direction of Dr. Qin Huang, performs quantitative PCRs for BCR-ABL.

Preceptorship at City of Hope will last for 3 to 4 weeks. 

Preceptorship Program lead - Professor David Snyder02 David Snyder

 

5) The University of Texas MD Anderson Cancer Center, Houston, USA08 MDAnderson 

The University of Texas M. D. Anderson Cancer Center is one of the world's most respected cancer centers and is often ranked as the best cancer hospital in the USA. The faculty numbers ~947 M.D.s and Ph.D.s with a total staff of more than 12,000. In its 469-bed hospital it treats ~60,000 cancer patients per year of whom approximately 11,000 participate in clinical trials of new therapies, the largest such program in the U.S. The institution currently spends more than $250 million per year in research and ranks first in the number of cancer-related grants awarded nationwide by the National Cancer Institute.

Preceptorships at the MD Anderson will last for 3 to 4 weeks. 
Preceptorship Program lead - Professor Jorge Cortesjorge cortes

 

6) The Royal Liverpool University Hospital, Liverpool, UK1269279206-royal liverpool hospital
Liverpool is a vibrant city in the North-West of England. The largest hospital is the centrally located Royal Liverpool University Hospital, which houses most specialist services for about 2.3 million people. The regional BMT and leukaemia service are in the Haematology department, run by 6 specialists in haematological oncology and 2 in thombosis/haemostasis, with excellent relations with nearby haematologist colleagues. Outpatients and related multidisciplinary clinical meetings are held several times a week. Immunophenotyping and molecular monitoring are carried out for almost all the region. Our research interests include mechanisms of resistance to imatinib and the newer drugs, and also the immune response to CML. We are one of the biggest UK recruiters into national and commercial clinical trials.

Preceptorships in Liverpool will last for 3 to 4 weeks.
ERSAP Preceptorship Program lead - Professor Richard ClarkRichard Clark

 

7) Hammersmith Hospital, London, England05 Hammersmith 

The Hammersmith Hospital, long famous for its research achievements, is now incorporated into the Academic Health Science Centre which is part of Imperial College London. It has a large faculty of active research and clinical investigators and a major population of medical students. The Department of Haematology was established more than 50 years ago and now has a long-standing special interest (amongst others) in chronic myeloid leukemia. The Hammersmith is home to the West London Renal and Transplant Centre, two large cancer treatment centres and a specialist cardiac service with a 24/7 primary angioplasty centre. 

Preceptorships at the Hammersmith will last for 3 weeks. 
Preceptorship Program lead - Professor Jane Apperley14 Jane Apperley

 

8) Hospital Universitario de la Princesa, Madrid, Spain06 Hospital de la Princesa - Madrid

Queen Isabel II laid the first stone of the Hospital de la Princesa, in 1852 in downtown Madrid. Since its foundation, the history of the Hospital has been associated with hematology. The Hematology Department was one of the Spanish pioneers in bone marrow transplantation and in the modern pharmacologic therapy of CML, introduced by Dr Juan Luis Steegmann. Maintaining a leadership position in bone marrow transplantation, it is also the hub of the Spanish Registry in CML and the leading center of the Region Madrid CML Group. A member of the European leukemia Net, the Hospital de la Princesa is the Spanish node of a continuing networking effort with outstanding research centers. Being a hospital located in the very center of Madrid, our spirit is to propel collaborative research efforts. Beneath this vision, the ERSAP Preceptorship Program of our center will include clinical, cytogenetic and molecular training.

Preceptorships at the Hospital Universitario de la Princesa will last for 4 weeks. 

Preceptorship Program lead: Professor Juan Luis Steegmann07 JLSteegmann

 

9) Fred Hutchinson Cancer Research Center, Seattle, USA03 FHCRC-Tour 

Through Seattle Cancer Care Alliance, researchers from the Fred Hutchinson Cancer Research Center (FHCRC) seek to speed the transfer of new diagnostic and treatment techniques from the research setting to patient care. This highly integrated approach supports the flow of scientific information among researchers, clinicians and patients, thus speeding the development of new cancer treatments. Part of the FHCRC, the Radich laboratory studies the molecular genetics of response, progression, and relapse in human leukemia. Research topics include the detection of minimal residual disease, dissecting the role of signal transduction abnormalities in leukemia, and constructing gene expression profiles of response and progression.

Preceptorships at the Fred Hutchinson Cancer Research Center will last for 3-4 weeks. 

Preceptorship Program lead - Professor Jerry Radichjerald radich

 

10) Paul O’Gorman Leukaemia Research Centre, Glasgow, Scotland16 Glasgow

The preceptorship will be held at the West of Scotland Cancer Centre in Glasgow, under the supervision of Professor Tessa Holyoake and Dr Mhairi Copland and will be personally developed for each successful applicant according to their needs. The work will likely involve training in diagnostic haematology, including Q-PCR for BCR-ABL measurement in patient samples. Applicants will also have the opportunity to observe in-patient and out-patient management of a range of haematological malignancies, including CML. There will be the opportunity to observe and interact with clinical trials staff and patients who are participating in a wide range of clinical trials. There will be the opportunity to shadow staff working in the area of CML stem cell research and the possibility of participating in an audit project or writing up a case report.

Preceptorships at the Paul O'Gorman Leukaemia Research Centre will last 4 weeks. 

Preceptorship Program lead: 

 

11) Almazov Federal Centre of Heart, Blood and Endocrinology, St Petersburg, Russia10 Russia site

Almazov Federal Heart, Blood and Endocrinology Centre (Almazov Centre) has three main activity directions, academic, scientific and clinical. The Institute of Hematology at the Almazov Centre is experienced in postgraduate training and preceptors will experience the latest medical advances in hematology, transfusion, stem cell transplant and molecular biology. Preceptorships concentrate on the following; CML pathogenesis, diagnostic procedures, novel therapies, the management of adverse events and management of resistant patients. Visitors will also observe cytogenetic and molecular analysis in the research and clinical laboratories. We are ready to share our knowledge of hematology and help continue to support patients in the fight against CML and other onco-hematology disorders.

Preceptorships at Almazov Federal Centre of Heart, Blood and Endocrinology will last 3 to 4 weeks. 

Preceptorship Program lead: Professor Andrey Zaritskeyandrey zaritsky